Celltrion Healthcare financials at a glance

+ Portfolio

The revenue of Celltrion Healthcare is reported as 1972.188 billion Won in the fiscal year 2023. The earnings were 949 Won per share in 2023, which was 0.41 lower than 2021. And about 202.11863 billion Won are reported as free cash flow in the financials of Celltrion Healthcare 2023. No dividends were paid to the shareholders of the Celltrion Healthcare stock KOSDAQ:A091990 in the financial year 2023.

₩1.97T

Revenue

₩949.00

Earnings Per Share

28.48%

Gross Margin %

₩201.24B

Free Cash Flow

Revenue

1,972,188.00

Earnings Per Share

949.00

Gross Margin %

28.48

Free Cash Flow

201,237.34

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016
Rev.	Revenue	N/A	₩1.97T	₩1.80T	₩1.63T	₩1.10T	₩713.49B	₩921.13B	₩0.00M
GM %	Gross Margin %	28.18%	28.48%	23.86%	33.29%	19.01%	9.65%	24.34%	0.00%
OM	Operating Margin	7.79%	11.61%	11.05%	22.25%	7.52%	-3.53%	16.68%	0.00%
EPS	Earnings Per Share	₩270.05	₩949.00	₩952.88	₩1.50k	₩419.59	₩71.30	₩972.52	₩921.31
Div.	Dividends	N/A	₩212.83	₩250.00	₩0.00	₩0.00	₩0.00	₩0.00	₩0.00
PR %	Payout Ratio %	0	22.43%	26.24%	0.00%	0.00%	0.00%	0.00%	0
Sha.	Shares	N/AM	161.31M	159.42M	159.29M	154M	158.1M	159.15M	116.57M
OCF	Operating Cash Flow	N/A	₩202.12B	₩-,175,312.37M	₩-22,608.11M	₩-,163,839.20M	₩-,184,228.50M	₩-,194,299.59M	₩0.00M
FCF	Free Cash Flow	N/A	₩201.24B	₩-,175,916.49M	₩-23,381.91M	₩-,164,110.45M	₩-,184,398.75M	₩-,194,606.25M	₩0.00M
FCFS	Free Cash Flow Per Share	₩783.62	₩1.24k	₩-1,292.76	₩-,164.27	₩-1,080.22	₩-1,244.59	₩-1,487.23	₩0.00

Celltrion Healthcare financials at a glance

Financials

Discover